Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026

Nuvation Bio (NYSE: NUVB) will report first quarter 2026 financial results and provide a business update on May 4, 2026.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Nuvation Bio (NYSE: NUVB) will report first quarter 2026 financial results and provide a business update on May 4, 2026. The company will host a live conference call and webcast at 4:30 p.m. ET for investors and the public.

Participants can register via the company Investor Relations website, join the call +1 833-461-5787 (U.S. toll-free) with access code 266802059, and review an archived recording for 90 days.

Argus Apr 21 session

-0.20% close to close Open Argus

Details

News Market Reaction – NUVB

On Apr 21, the first trading day after this news, NUVB closed 0.20% below the previous close.

Data tracked by StockTitan Argus for the Apr 21 session.

Key Figures

Earnings call date: May 4, 2026 Earnings call time: 4:30 p.m. ET Webcast archive length: 90 days +2 more

Earnings call date: May 4, 2026; Scheduled Q1 2026 results and business update
Earnings call time: 4:30 p.m. ET; Start time for Q1 2026 conference call
Webcast archive length: 90 days; Replay availability on company website
Conference call number: +1 833-461-5787; U.S. toll-free dial-in for Q1 2026 call
Access code: 266802059; Access code for live conference call

Previous Earnings date Reports

1 past event · Latest: Feb 17

Same Type 1 event

Feb 17
Earnings date notice

24h Move

-1.9%

Scheduled Q4 and full-year 2025 results call on March 2, 2026.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

04/20/2026 - 04:05 PM

NEW YORK, April 20, 2026 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced it will host a conference call and webcast on Monday, May 4, 2026, at 4:30 p.m. ET to discuss its financial results and business updates for the first quarter of 2026.

Investors and the general public are invited to listen to the live webcast and may register on the Investor Relations section of the Nuvation Bio website. To access the live conference call, participants can dial +1 833-461-5787 (U.S. toll-free) and enter access code 266802059. An archived recording will be available on Nuvation Bio's website for 90 days following the event.

About Nuvation Bio
Nuvation Bio is a global oncology company focused on tackling some of the toughest challenges in cancer treatment with the goal of developing therapies that create a profound, positive impact on patients' lives. Our diverse pipeline includes taletrectinib (IBTROZI^®), a next-generation ROS1 inhibitor; safusidenib, a brain-penetrant IDH1 inhibitor; and an innovative drug-drug conjugate (DDC) program.

Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York, San Francisco, Boston, and Shanghai. For more information, visit www.nuvationbio.com or follow the company on LinkedIn and X (@nuvationbioinc).

Media and Investor Contacts

Nuvation Bio Investor Contact
JR DeVita
ir@nuvationbio.com

Nuvation Bio Media Contact
Kaitlyn Nealy
media@nuvationbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvation-bio-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-may-4-2026-302747586.html

SOURCE Nuvation Bio Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Nuvation Bio (NUVB) release Q1 2026 results and host the webcast?

The company will report Q1 2026 results and host a webcast on May 4, 2026 at 4:30 p.m. ET. According to Nuvation Bio, the event will cover first quarter financial results and a business update for investors and the public.

How can investors access the NUVB May 4, 2026 conference call and webcast?

Investors may join the live webcast via the company's Investor Relations site or dial +1 833-461-5787 with access code 266802059. According to Nuvation Bio, registration is available on its Investor Relations webpage before the event.

Will Nuvation Bio (NUVB) provide a recording of the May 4, 2026 webcast?

Yes, an archived recording will be available on the company website for 90 days after the event. According to Nuvation Bio, the recording will be posted to the Investor Relations section following the live webcast.

What topics will Nuvation Bio (NUVB) cover during the May 4, 2026 presentation?

The presentation will discuss Q1 2026 financial results and a company business update. According to Nuvation Bio, management will review performance and recent corporate developments relevant to investors.

Is the Nuvation Bio (NUVB) May 4, 2026 call open to the general public?

Yes, the live webcast and conference call are open to investors and the general public. According to Nuvation Bio, anyone may listen by registering on the Investor Relations website or dialing the provided U.S. toll-free number.

Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026